Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Vertex Pharmaceuticals Inc (VRTX)

NASDAQ
Currency in USD
Disclaimer
422.78
+3.79(+0.90%)
Closed
After Hours
423.40+0.62(+0.15%)

VRTX Comments

UBS initiated coverage with a buy. Price target $287. We'll see what earnings bring.
expectations for next week?
it is on 29th oct.
i checked. it is on 29th oct.
i checked. it is on 29th oct.
Where are the earnings? Wasn’t it today?
i checked. it is on 29th oct.
i checked. it is on 29th oct.
Yeah. ***website, I sold because of them!
will level out around 200 until the pause it's over
it starts hurting me. hmm
haha why
Is keeping this through earnings a good play?
Well, depends if the chance if gaining a lot is worth the risk of losing a lot, to you. It could jump 20%, but it could also fall 20%. You never know with these stocks...
Add more before earnings.
It will back up tomorrow
Easily by next week
Such a discount, I got a nice bunch of  this stocks.
So basically their drug F’ed patients up! Right?
Phase 2 study, they are not patients, they are subjects.
So basically their drug F’ed patients up! Right?
Perfect day to LONG
Tomorrow it's likely to go another couple percent down
what happen to -20%?
just google and you'll see. I'm buying at 210 if it gets to that low.
700K sold just before close 4/13 at 252 handle.
good buy to jump on now even
and now?
I think it will bounce at support (217.78)
also long from $226
,
long @223
why down 1.84% today?
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.